Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JOHNSON & JOHNSONJNJ · Entity 2722 | EVP, WW Chair, MedTech | September 02, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JOHNSON & JOHNSON
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,447 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-02 · Exercise / conversion · Acquired 11,070 · Balance 36,517 Row 2 · 2026-09-02 · Sale · Disposed 11,070 · Balance 25,447 Row 3 · 2026-09-02 · Exercise / conversion · Acquired 22,527 · Balance 47,974 Row 4 · 2026-09-02 · Sale · Disposed 22,527 · Balance 25,447 |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $131.94 · Expires 2029-02-11 | Direct | 0 |
Reported balance
After 2026-09-02 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-02 · Exercise / conversion · Disposed 11,070 · Balance 0 F3: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $151.41 · Expires 2030-02-10 | Direct | 0 |
Reported balance
After 2026-09-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-02 · Exercise / conversion · Disposed 22,527 · Balance 0 F3: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k | 758 |
Reported balance
Holding disclosure · report date 2026-09-02 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 758 F1: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026). |
| Common StockSEC Table I · non-derivative | IndirectBy ESOP | 46 |
Reported balance
Holding disclosure · report date 2026-09-02 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 46 F2: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026). |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).
F2: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).
F3: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 4, 2026 13:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 22,527 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · derivative · entry 8 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,527 shares Expires 2030-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 13:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 11,070 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · derivative · entry 7 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,070 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 13:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 22,527 | $274.74 | $6,189,067.98 |
DisclosureSEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 4 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,447 Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 13:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 22,527 | $151.41 | $3,410,813.07 |
DisclosureSEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 3 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 13:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 11,070 | $274.74 | $3,041,371.80 |
DisclosureSEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,447 Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 13:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 11,070 | $131.94 | $1,460,575.80 |
DisclosureSEC source: 0000200406-26-000179 · wk-form4_1788527285.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 1,322 | $245.66 | $324,762.52 |
DisclosureSEC source: 0000200406-26-000046 · wk-form4_1771885218.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,447 Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 8,998 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 22 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,998 shares Expires 2028-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 13,625 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 21 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,625 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 8,998 | $244.53 | $2,200,280.94 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 12 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769 Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 8,998 | $129.51 | $1,165,330.98 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 11 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 13,625 | $244.20 | $3,327,225.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 10 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769 F7 · price: This transaction was executed in multiple trades at prices ranging from $244.20 to $244.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 13,625 | $115.67 | $1,576,003.75 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 9 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 2,548 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 20 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,548 Underlying: Common Stock · 2,548 shares Expires not disclosed F12 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F12 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F12 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 35,489 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 19 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,489 Underlying: Common Stock · 35,489 shares Expires 2036-02-15 F11 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 18 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,051 Underlying: Common Stock · 1,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 1,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 17 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,028 Underlying: Common Stock · 1,028 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 448 | $243.45 | $109,065.60 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 8 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 7 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 15 | $243.45 | $3,651.75 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 6 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,191 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 4,378 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 16 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. F3 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 15 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 1,816 | $244.55 | $444,102.80 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 4 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,178 F4 · shares: Shares withheld for payment of taxes upon vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 4,378 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 3 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 8 | $244.55 | $1,956.40 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,616 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:11 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 01:41 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 4,378 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000026 · wk-form4_1770860486.xml · derivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,378 Underlying: Common Stock · 4,378 shares Expires not disclosed F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. F2 · balance_after: The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 02:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 15,571 | $101.87 Strike: $101.87 | $1,586,217.77 |
DisclosureSEC source: 0001998491-26-000002 · wk-form4_1770777998.xml · derivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,571 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 02:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 10,335 | $239.99 | $2,480,296.65 |
DisclosureSEC source: 0001998491-26-000002 · wk-form4_1770777998.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,125 F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 02:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 15,571 | $101.87 | $1,586,217.77 |
DisclosureSEC source: 0001998491-26-000002 · wk-form4_1770777998.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 403 | $156.15 | $62,928.45 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 6 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,098 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 9 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,056 Underlying: Common Stock · 1,029 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 3,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000076 · wk-form4_1740004292.xml · derivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,077 Underlying: Common Stock · 3,077 shares Expires not disclosed F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F2 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 49,878 | $0.00 Strike: $156.15 | $0.00 |
DisclosureSEC source: 0000200406-25-000076 · wk-form4_1740004292.xml · derivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,878 Underlying: Common Stock · 49,878 shares Expires 2035-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 1,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 8 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 639 | $156.71 | $100,137.69 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 4 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,472 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 1,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 3 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 193 | $155.26 | $29,965.18 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,346 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000062 · wk-form4_1739933175.xml · derivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 1,015 | $156.71 | $159,060.65 |
DisclosureSEC source: 0000200406-25-000062 · wk-form4_1739933175.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,889 F2 · shares: Shares withheld for payment of taxes upon vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 02:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000062 · wk-form4_1739933175.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · derivative · entry 7 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499 Underlying: Common Stock · 499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. F5 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 02:33 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000060 · wk-form4_1739932395.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:10 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-25-000023 · wk-form4_1739401822.xml · derivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,806 Underlying: Common Stock · 2,806 shares Expires not disclosed F1 · derivative.exercise_price: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F1 · derivative.expiration_date: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022. F2 · balance_after: The total number of PSUs has been revised to reflect that certain PSUs, originally granted on February 14, 2022, were forfeited based on performance conditions set forth in the award agreement. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 3,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002535 · doc4.xml · derivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,085 Underlying: Common Stock · 3,085 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:56 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 49,658 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002535 · doc4.xml · derivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,658 Underlying: Common Stock · 49,658 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002179 · doc4.xml · derivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998 Underlying: Common Stock · 499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 250 | $157.85 | $39,462.50 |
DisclosureSEC source: 0001225208-24-002179 · doc4.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,040 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.